<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Increased concentrations of C-reactive protein and interleukin-6, a finding suggestive of the presence of <z:mp ids='MP_0001845'>inflammation</z:mp>, have been observed in Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>In such patients, C-reactive protein was predictive of diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Studies on low-grade inflammatory markers and <z:hpo ids='HP_0000112'>nephropathy</z:hpo> in Type 1 diabetic patients have shown conflicting results </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore we studied whether low-grade <z:mp ids='MP_0001845'>inflammation</z:mp> is associated with diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> in Type 1 diabetic patients </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: We divided 194 Type 1 diabetic patients into three groups from the Finnish Diabetic <z:hpo ids='HP_0000112'>Nephropathy</z:hpo> Study based upon their albumin excretion rate </plain></SENT>
<SENT sid="5" pm="."><plain>Patients with normoalbuminuria (n=67) had no <z:chebi fb="0" ids="35674">antihypertensive</z:chebi> medication or signs of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>, while patients with <z:mp ids='MP_0002959'>microalbuminuria</z:mp> (n=64) or macroalbuminuria (n=63) were <z:hpo ids='HP_0000001'>all</z:hpo> treated with an <z:chebi fb="0" ids="35457">angiotensin-converting enzyme inhibitor</z:chebi>, a drug that could attenuate low-grade <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>As a measure of insulin sensitivity we used estimated <z:chebi fb="105" ids="17234">glucose</z:chebi> disposal rate </plain></SENT>
<SENT sid="7" pm="."><plain>C-reactive protein was measured by radioimmunoassay and interleukin-6 by high sensitivity enzyme immunoassay </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: C-reactive protein was higher in micro- and macroalbuminuric patients compared to normoalbuminuric patients (normoalbuminuria 2.0+/-1.7, <z:mp ids='MP_0002959'>microalbuminuria</z:mp> 2.6+/-1.7, macroalbuminuria 2.9+/-2.5 mg/l; p=0.016), while interleukin-6 increased in parallel with the severity of the <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">renal disease</z:e> (1.9+/-1.5, 2.9+/-3.3, 3.6+/-3.1 ng/l; p&lt;0.0001) </plain></SENT>
<SENT sid="9" pm="."><plain>In multiple regression analysis albumin excretion rate was the only variable independently associated with C-reactive protein (p=0.03), whereas albumin excretion rate (p=0.0003), <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> (p=0.0135) and duration of <z:mp ids='MP_0002055'>diabetes</z:mp> (p=0.0176) were independently associated with interleukin-6 </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS/INTERPRETATION: Low-grade inflammatory markers are associated with diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> in Type 1 diabetic patients </plain></SENT>
<SENT sid="11" pm="."><plain>The predictive value needs to be assessed </plain></SENT>
</text></document>